Nanotechnology in metastatic cancer treatment: Current Achievements and Future Research Trends

被引:24
作者
Gonciar, Diana [1 ,3 ]
Mocan, Teodora [2 ,3 ]
Matea, Cristian Tudor [1 ,3 ]
Zdrehus, Claudiu [1 ,3 ]
Mosteanu, Ofelia [1 ,3 ]
Mocan, Lucian [1 ,3 ]
Pop, Teodora [3 ]
机构
[1] Iuliu Hatieganu Univ Med & Pharm, Surg Clin 3, 19-21 Croitorilor St, Cluj Napoca, Romania
[2] Iuliu Hatieganu Univ Med & Pharm, Dept Physiol, Cluj Napoca, Romania
[3] Reg Inst Gastroenterol & Hepatol Prof Dr Octavian, Nanomed Dept, Cluj Napoca, Romania
来源
JOURNAL OF CANCER | 2019年 / 10卷 / 06期
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR RECEPTOR; PHOTOTHERMAL THERAPY; GOLD-NANOPARTICLES; FACTOR-BETA; SIGNALING PATHWAY; DRUG-RESISTANCE; CARCINOMA-CELLS; BREAST-CANCER; FACTOR-ALPHA;
D O I
10.7150/jca.28394
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The systemic spread of malignant cells from a primary site, a process termed metastasis represents a global challenge in cancer treatment. There is a real need to develop novel therapy strategies and nanomedicine may have remarkable and valuable contribution through specific and selective delivery of chemotherapeutic agents, through its intrinsic cytotoxic activity or through imaging applications, appealing also in the context of cancer personalized therapy. This review is focused on the applications of nanoparticles in the treatment of metastatic cancer, particularly on the possible effect on cell stabilization, growth inhibition, eventual interaction with adhesion molecules and antiangiogenic effect.
引用
收藏
页码:1358 / 1369
页数:12
相关论文
共 50 条
  • [41] Impact of cetuximab in current treatment of metastatic colorectal cancer
    Sotelo Lezama, Miguel Jhonatan
    Sastre Valera, Javier
    Diaz-Rubio Garcia, Eduardo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (03) : 387 - 399
  • [42] Treatment for the endocrine resistant breast cancer: Current options and future perspectives
    Liu, Chun-Yu
    Wu, Chia-Yun
    Petrossian, Karineh
    Huang, Tzu-Ting
    Tseng, Ling-Ming
    Chen, Shiuan
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 172 : 166 - 175
  • [43] Cancer nanotechnology: current status and perspectives
    Kemp, Jessica A.
    Kwon, Young Jik
    NANO CONVERGENCE, 2021, 8 (01)
  • [44] Photothermal therapy-mediated autophagy in breast cancer treatment: Progress and trends
    Kadkhoda, Jamileh
    Tarighatnia, Ali
    Tohidkia, Mohammad Reza
    D. Nader, Nader
    Aghanejad, Ayuob
    LIFE SCIENCES, 2022, 298
  • [45] Targeted therapy in refractory thyroid cancer: current achievements and limitations
    Brilli, Lucia
    Pacini, Furio
    FUTURE ONCOLOGY, 2011, 7 (05) : 657 - 668
  • [46] RECENT TRENDS IN DIABETES TREATMENT USING NANOTECHNOLOGY
    Subramani, Karthikeyan
    Pathak, Sarvadaman
    Hosseinkhani, Hossein
    DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2012, 7 (01) : 85 - 95
  • [47] Nanotechnology in Retinal Disease: Current Concepts and Future Directions
    Mehta, Nalin J.
    Mehta, Sachin N.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2024, 40 (01) : 3 - 12
  • [48] Current evidence for cancer stem cells in gastrointestinal tumors and future research perspectives
    Lopez-Gomez, Miriam
    Casado, Enrique
    Munoz, Marta
    Alcala, Sonia
    Moreno-Rubio, Juan
    D'Errico, Gabriele
    Maria Jimenez-Gordo, Ana
    Salinas, Silvia
    Sainz, Bruno, Jr.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 107 : 54 - 71
  • [49] Therapies for the Treatment of Advanced/Metastatic Estrogen Receptor-Positive Breast Cancer: Current Situation and Future Directions
    Rej, Rohan Kalyan
    Roy, Joyeeta
    Allu, Srinivasa Rao
    CANCERS, 2024, 16 (03)
  • [50] The new era of nanotechnology, an alternative to change cancer treatment
    Jurj, Ancuta
    Braicu, Cornelia
    Pop, Laura-Ancuta
    Tomuleasa, Ciprian
    Gherman, Claudia Diana
    Berindan-Neagoe, Ioana
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2871 - 2890